Texas HB5022 prohibits the administration of immunization products containing mRNA material, except for cancer or genetic disorder treatments.
HB5022 amends the Health and Safety Code to prohibit the administration of products containing mRNA material for immunization purposes. The term "mRNA material" refers to substances that introduce messenger ribonucleic acid corresponding to a viral protein. This prohibition does not apply to products used for treating cancer or genetic disorders. The law takes effect on September 1, 2025, and expires on September 1, 2035.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.